About: Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use?
Creator	Funck-Brentano, Christian Gligorov, Joseph Solas, Caroline Spano, Jean-Philippe Fenioux, Charlotte Gougis, Paul Veyri, Marianne
source	Elsevier; Medline; PMC
abstract	• More safety data is needed to treat COVID-19 symptomatic patients with anticancer drugs known to increase infections. • We summarized immunosuppressing anticancer drugs; other drugs were studied for drug-drug interactions with antiviral medicines. • A ready-to-use table synthetize these pharmacokinetic and pharmacodynamic interactions between antiviral and anticancer drugs.
has issue date	2020-06-10(xsd:dateTime)
bibo:doi	10.1016/j.ejca.2020.05.027
bibo:pmid	32610172
has license	no-cc
sha1sum (hex)	dcc821f0ce0c325cdb91b63ed53b39b95a78cb6b
schema:url	https://doi.org/10.1016/j.ejca.2020.05.027
resource representing a document's title	Anticancer drugs and COVID-19 antiviral treatments in cancer patients: what can we safely use?
has PubMed Central identifier	PMC7284279
has PubMed identifier	32610172
schema:publication	Eur J Cancer
resource representing a document's body	covid:dcc821f0ce0c325cdb91b63ed53b39b95a78cb6b#body_text
is schema:about of	named entity 'patients' named entity 'patients' named entity 'cancer patients' named entity 'Anticancer drugs' named entity 'Anticancer drugs' named entity 'anticancer drugs' named entity 'placebo' named entity 'Dabrafenib' named entity 'pandemics' named entity 'Kaletra' named entity 'substrate' named entity 'metabolized' named entity 'control group' named entity 'anticancer drugs' named entity 'pharmacokinetic' named entity 'Antiviral' named entity 'CYP3A4' named entity 'immunosuppressive properties' named entity 'metabolism' named entity 'enzalutamide' named entity 'FDA labels' named entity 'CYP3A4' named entity 'lopinavir' named entity 'enzalutamide' named entity 'antiretrovirals' named entity 'COVID-19' named entity 'hepatotoxicity' named entity 'neutropenia' named entity 'enzalutamide' named entity 'pharmacodynamic' named entity 'azithromycin' named entity 'combination therapy' named entity 'CYP3A4' named entity 'cytochrome' named entity 'PDL1' named entity 'inducer' named entity 'Red arrows' named entity 'Ritonavir' named entity 'pharmacological' named entity 'pharmacokinetic interactions' named entity 'enzalutamide' named entity 'CYP3A4' named entity 'COVID-19' named entity 'CYP3A4' named entity 'immunosuppressive' named entity 'CYP3A4' named entity 'pharmacokinetic' named entity 'hepatotoxicity' named entity 'anticancer drugs' named entity 'liver toxicities' named entity 'clinically significant' named entity 'Immunotherapy' named entity 'standard of care' named entity 'immunosuppressive' named entity 'risk of death' named entity 'therapeutic index' named entity 'Hydroxychloroquine' named entity 'nephrotoxicity' named entity 'antiviral drugs' named entity 'hepatic' named entity 'clinical trials' named entity 'interact' named entity 'EBOV' named entity 'acute respiratory distress syndrome' named entity 'pharmacokinetic interactions' named entity 'prostate cancer' named entity 'liver toxicities' named entity 'Favipiravir' named entity 'substrate' named entity 'Ritonavir' named entity 'comorbidities' named entity 'anticancer drugs' named entity 'hydroxychloroquine' named entity 'broad spectrum' named entity 'HIV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software